TAR-independent_JJ
transactivation_NN
by_IN
Tat_NN
in_IN
cells_NNS
derived_VBN
from_IN
the_DT
CNS_NN
:_:
a_DT
novel_JJ
mechanism_NN
of_IN
HIV-1_NN
gene_NN
regulation_NN
._.

The_DT
Tat_NN
protein_NN
of_IN
human_JJ
immunodeficiency_NN
virus_NN
type_NN
1_CD
-LRB-_-LRB-
HIV-1_NN
-RRB-_-RRB-
is_VBZ
essential_JJ
for_IN
productive_JJ
infection_NN
and_CC
is_VBZ
a_DT
potential_JJ
target_NN
for_IN
antiviral_JJ
therapy_NN
._.

Tat_NN
,_,
a_DT
potent_JJ
activator_NN
of_IN
HIV-1_NN
gene_NN
expression_NN
,_,
serves_VBZ
to_TO
greatly_RB
increase_VB
the_DT
rate_NN
of_IN
transcription_NN
directed_VBN
by_IN
the_DT
viral_JJ
promoter_NN
._.

This_DT
induction_NN
,_,
which_WDT
seems_VBZ
to_TO
be_VB
an_DT
important_JJ
component_NN
in_IN
the_DT
progression_NN
of_IN
acquired_VBN
immune_JJ
deficiency_NN
syndrome_NN
-LRB-_-LRB-
AIDS_NN
-RRB-_-RRB-
,_,
may_MD
be_VB
due_JJ
to_TO
increased_VBN
transcriptional_JJ
initiation_NN
,_,
increased_VBN
transcriptional_JJ
elongation_NN
,_,
or_CC
a_DT
combination_NN
of_IN
these_DT
processes_NNS
._.

Much_JJ
attention_NN
has_VBZ
been_VBN
focused_VBN
on_IN
the_DT
interaction_NN
of_IN
Tat_NN
with_IN
a_DT
specific_JJ
RNA_NN
target_NN
termed_VBN
TAR_NN
-LRB-_-LRB-
transactivation_NN
responsive_JJ
-RRB-_-RRB-
which_WDT
is_VBZ
present_JJ
in_IN
the_DT
leader_NN
sequence_NN
of_IN
all_DT
HIV-1_NN
mRNAs_NNS
._.

This_DT
interaction_NN
is_VBZ
believed_VBN
to_TO
be_VB
an_DT
important_JJ
component_NN
of_IN
the_DT
mechanism_NN
of_IN
transactivation_NN
._.

In_IN
this_DT
report_NN
we_PRP
demonstrate_VBP
that_IN
in_IN
certain_JJ
CNS-derived_JJ
cells_NNS
Tat_NN
is_VBZ
capable_JJ
of_IN
activating_VBG
HIV-1_NN
through_IN
a_DT
TAR-independent_JJ
pathway_NN
._.

A_DT
Tat-responsive_JJ
element_NN
is_VBZ
found_VBN
upstream_JJ
within_IN
the_DT
viral_JJ
promoter_NN
that_WDT
in_IN
glial-derived_JJ
cell_NN
lines_NNS
allows_VBZ
transactivation_NN
in_IN
the_DT
absence_NN
of_IN
TAR_NN
._.

Deletion_NN
mapping_NN
and_CC
hybrid_NN
promoter_NN
constructs_NNS
demonstrate_VBP
that_IN
the_DT
newly_RB
identified_VBN
Tat-responsive_JJ
element_NN
corresponds_VBZ
to_TO
a_DT
sequence_NN
within_IN
the_DT
viral_JJ
long_JJ
terminal_JJ
repeat_NN
-LRB-_-LRB-
LTR_NN
-RRB-_-RRB-
previously_RB
identified_VBN
as_IN
the_DT
HIV-1_NN
enhancer_NN
,_,
or_CC
NF-kappa_NN
B_NN
domain_NN
._.

DNA_NN
band-shift_NN
analysis_NN
reveals_VBZ
NF-kappa_NN
B_NN
binding_NN
activity_NN
in_IN
glial_JJ
cells_NNS
that_WDT
differs_VBZ
from_IN
that_DT
present_JJ
in_IN
T_NN
lymphoid_JJ
cells_NNS
._.

Further_RB
,_,
we_PRP
observe_VBP
that_IN
TAR-deleted_JJ
mutants_NNS
of_IN
HIV-1_NN
demonstrate_VBP
normal_JJ
late_JJ
gene_NN
expression_NN
in_IN
glial_JJ
cells_NNS
as_IN
evidenced_VBN
by_IN
syncytia_NN
formation_NN
and_CC
production_NN
of_IN
viral_JJ
p24_NN
antigen_NN
._.

-LRB-_-LRB-
ABSTRACT_NN
TRUNCATED_VBN
AT_IN
250_CD
WORDS_NNS
-RRB-_-RRB-

